| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.8 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |